Additionally, a previous study reported that CD90+ liver cancer cell-derived exosomes could facilitate angiogenesis in the TME, and lncRNA profiles revealed that lncRNA-H19 is enriched in exosomes and acts as a possible mediator of angiogenic effects [35]. The gene discussed is H19; the disease is liver cancer.